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ABSTRACT
MSH2 is a central component of the mismatch repair
pathway that targets mismatches arising during DNA
replication, homologous recombination (HR) and in
response to genotoxic stresses. Here, we describe
the function of MSH2 in the moss Physcomitrella
patens, as deciphered by the analysis of loss of
function mutants. Ppmsh2 mutants display pleiotro-
pic growth and developmental defects, which reflect
genomic instability. Based on loss of function of the
APT gene, we estimated this mutator phenotype to
be at least 130 times higher in the mutants than in
wild type. We also found that MSH2 is involved in
some but not all the moss responses to genotoxic
stresses we tested. Indeed, the Ppmsh2 mutants
were more tolerant to cisplatin and show higher
sensitivity to UV-B radiations. PpMSH2 gene involve-
ment in HR was studied by assessing gene targeting
(GT) efficiency with homologous and homeo-
logous sequences. GT efficiency with homologous
sequences was slightly decreased in the Ppmsh2
mutant compared with wild type. Strikingly GT effici-
ency with homeologous sequences decreased
proportionally to sequence divergence in the wild
type whereas it remained unaffected in the mutants.
Those results demonstrate the role of PpMSH2 in the
maintenance of genome integrity and in homologous
and homeologous recombination.
INTRODUCTION
The mismatch repair (MMR) system is evolutionarily highly
conserved and plays an essential role in maintaining genome
stability (1). In all organisms, MMR is best known for its role
in the post-replication repair of DNA polymerization errors. It
keeps the rate of mutations due to nucleotide misincorporation
and polymerase slippage at an acceptable low level (2). MMR
proteins also recognize mismatches in heteroduplex recom-
bination intermediates. In somatic cells, they display an
antirecombination activity that inhibits recombination bet-
ween homeologous sequences present in a single genome
(such as allelic genes in diploid cells and members of multi-
gene families) and thus preserves genome integrity (2). This
activity also prevents genetic recombination between different
but related species and thus contributes to the definition of
species. Additionally, MMR plays a role in some types of
nucleotide excision repair, which are responsible for repair
of physical and chemical damage to DNA. It also participates
in a cell-cycle checkpoint control system by recognizing cer-
tain types of DNA damage and promoting cell-cycle arrest or
triggering apoptosis pathways (3,4).
The methyl-directed MMR system of Escherichia coli is
composed of MutS and MutL proteins [Mut for mutator
phenotype, because they were isolated from mutant strains
with high frequencies of spontaneous mutations] (1,3). The
MutS proteins are conserved from bacteria to mammals. In
eukaryotes MutS homologs (MSH) are encoded by small
multigene families, whose members can associate into het-
erodimers that have discrete roles in MMR-related processes
(2). For example, MSH2/MSH6 heterodimers recognize and
stimulate the repair of single base-pair mismatches while
MSH2/MSH3 heterodimers recognize small insertion/deletion
loops (2). The MSH2 protein is a central component of the
eukaryotic MMR system and is present in all heterodimers. It
is crucial for the repair of all mismatched lesions, whereas
other MSH proteins modulate the function of MSH2 depend-
ing on the different lesion types or developmental stages.
The msh2 mutants in yeast and mammals show (i) micro-
satellite instability, (ii) a mutator phenotype characterized by a
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high spontaneous mutation rate, (iii) an increased recombina-
tion frequency between diverged DNA sequences (homeolo-
gous) and (iv) tolerance to certain types of chemical and
physical treatments that damage DNA (5–8). In Caenorhab-
ditis elegans, loss of MSH2 is associated with microsatellite
instability, a mutator phenotype and reduced fertility (9).
However, in plants, the effect of MSH2 mutations is still
poorly understood. In Arabidopsis thaliana, Hoffman et al.
(10) have shown rapid accumulation of mutations and
microsatellite instability during seed-to-seed propagation of
Atmsh2 defective lines. However, the molecular tools are
not available to evaluate the role of MSH2 in the mechanism
of homologous recombination (HR) in A.thaliana and other
higher plants. This type of study in plants is currently only
possible in the moss Physcomitrella patens.
The moss P.patens is unique in the plant kingdom in that it
allows high efficiency of gene targeting (GT) via HR (11).
Thus, it is possible to use gene knock-out and allele replace-
ment methods in this organism. This allows to examine for the
first time the importance of MMR in a multicellular organism
in which targeted integration by HR is a major transformation
pathway [suggesting that the repair of double strand breaks
(DSBs) occurs predominantly by HR]. Recently, we have
isolated the PpMSH2 gene (12). We now have generated
Ppmsh2 disruptants to examine the role of MSH2 in the
DNA metabolism of P.patens. Here, we show that PpMSH2
is involved in the control of genome integrity and that it is a
barrier to recombination between divergent DNA sequences.
Furthermore, in the absence of PpMSH2, moss development is
dramatically affected most likely as a consequence of a strong
mutator phenotype that is directly revealed by the dominance
of the haplophase during its development.
MATERIALS AND METHODS
Plant material and culture conditions
The Gransden wild-type strain of P.patens (13) was used in
this study. Protonemal tissue was propagated on PpNO3 med-
ium (14), supplemented with 2.7 mM NH4-tartrate (standard
medium). Cultures were grown in 9 cm Petri dishes on med-
ium solidified with 0.7% Agar (Biomar) and overlaid with a
cellophane disk (Cannings, Bristol). Cultures were illuminated
with a light regime of 16 h light/8 h darkness and a quantum
irradiance of 80 mE m2 s1 (standard conditions). Sporoge-
nesis was performed in Magenta box in which the tested strains
were grown aside the self sterile but cross fertile strain nic-
B5ylo6 (13) on minimal PpNO3 medium. Crosses were grown
in standard conditions for 6–8 weeks (i.e. until about 50 game-
tophores reached full development), then irrigated with sterile
water and transferred for 2 weeks in growth chambers set at
15C with 10 h of light per day and a quantum irradiance of
15 mE m2 s1. The development of archegonia, antheridia
and spore capsules was followed visually during the next
month. Antheridia and archegonia were manually dissected
for further microscopic observation.
Molecular cloning
We used standard methods for all molecular cloning (15).
Using genomic P.patens DNA as starting template, we
amplified a 2340 bp PCR fragment covering an internal frag-
ment of the MSH2 genomic region (Gene Bank: DQ117988)
and inserted it into the TA-cloning vector pCRII (Invitrogen,
Groningen, The Netherlands) to produce PpMSH2 (oligonu-
cleotide sequences can be provided on request). To obtain
PpMSH2-KO, a 465 bp 50 targeting fragment (coordinate
2557–3022 in DQ117988) and a 598 bp 30 targeting fragment
(coordinate 4614–5212 in DQ117988) were recovered by
restriction from PpMSH2 and inserted upstream (50) and
downstream (30) of the loxP sites flanking the resistance cas-
sette of pBSK35S-NPTII-lox (supplied by Dr Laloue, INRA
Versailles). Vector pBSK35S-NPTII-lox carries a neomycin
phosphotransferase resistance gene driven by the 35S CaMV
promoter and flanked by two LoxP sites in direct orientation.
The antibiotic resistance cassette is in the same orientation
with regard to the transcription of PpMSH2.
To obtain PpAPT-KO, a 3995 bp Xba1 and EcoRI fragment
covering the APT genomic sequence (Gene Bank: DQ117987),
was inserted in pBlueScript KS (Stratagene), forming
PpAPT1. The ATG codon is 1217 bp 30 of the XbaI site
and the stop codon is 881 bp 50 of the EcoRI site in this
PpAPT fragment. An internal 1102 bp BamHI fragment
was deleted by digestion of the PpAPT1 vector, to produce
PpAPTD. We generated homeologous variants of this target-
ing cassette by mutating the PpAPTD sequence by mutagenic
PCR using the Cadwell and Joyce (16) protocol. Successive
APT variants were generated until we reached 3% diverg-
ence within the PpAPT original fragment. A BamHI fragment
containing the hygromycin phosphotransferase gene (HptII)
driven by the 35S CaMV promoter was recovered from plas-
mid pGL2 (17) and ligated into the BamHI site of PpAPTD and
of the variants to produce the homologous and homeologous
PpAPT-KO vectors (Figure 4).
Protoplasts isolation and regeneration
Protoplasts were isolated from 6-day-old protonema by
incubation for 40 min in 1% Driselase (Fluka 44585) dissolved
in 0.47 M mannitol. The suspension was filtered successively
through 80 and 40 mm stainless steel sieves. Protoplasts were
sedimented by low-speed centrifugation (600 g for 5 min at
20C) and washed twice with 0.47 M mannitol. Protoplasts
were then resuspended at 1.2 · 106 protoplasts/ml in MMM
solution (0.47 M mannitol, 15 mM MgCl2 and 0.1% MES,
pH 5.6) for transformation. For growth assay and phenotypic
analyses, protoplasts were resuspended at a density of ca.
1–3 · 104 protoplasts/ml in mannitol 0.47 M containing 0.5%
agar. Two ml of suspension were spread on cellophane disks
covering standard medium supplemented with 0.5% glucose
and 0.36 M mannitol (PPM). Regeneration was conducted in
standard growth conditions. After 1 week of regeneration,
protoplasts were transferred to standard medium without
mannitol.
Transformation of protoplasts
Moss protoplasts (1.2 · 106) were transformed as described
previously (18) with PpMSH2-KO digested with AgeI and
AatII, which generate DSBs within the genomic MSH2
sequence. Primary transformants were selected in the presence
of 50 mg/l paramomycin (Duchefa P0141, Haarlem, The
Netherlands). Small pieces of the protonema tissue (2 mm
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in diameter) of primary P.patens transformants were then
transferred onto standard medium without selection and
cultured for 15 days. A second round of selection allowed
the isolation of stable transformants, by transferring small
pieces of protonema tissue from the previous colonies onto
standard medium containing 50 mg/l G418 (Duchefa G0175,
Haarlem, The Netherlands) (paramomycin and G418 belong to
the kanamycin family of antibiotics).
Molecular analysis of Msh2 knockouts
Moss DNA was extracted from 200 mg of fresh protonema
tissue ground in 220 ml of extraction buffer (220 mM Tris–
HCl, pH 7.5, 250 mM NaCl, 25 mM EDTA and 0.5% SDS)
with an electric pestle in the presence of sand. After centrifu-
gation, DNA was precipitated with isopropanol at room tem-
perature. The pellet was dried and resuspended with 100 ml
sterile water. Stable disruptants of the PpMSH2 gene were
screened by PCR for the incorporation of the resistance
cassette into the MSH2 locus. We used primers specific for
the resistance cassette (Uc: TATTTTTGGAGTAGACAAGC-
GTGTCGT and Lc: CCGCTTCCTCGTGCTTTACGGTAT)
and primers specific for the PpMSH2 sequence outside the
transformation construct (PpMSH2#4: CAATGTCACTGA-
GAGCAAAACG and PpMSH2#5: CACACTGATCTCT-
GCTCGGTCG).
Moss RNA was isolated using the RNAeasy kit (Qiagen)
starting with 100 mg of fresh protonema. We obtained
doubled-stranded cDNAs corresponding to mRNAs expressed
in 6-day-old protonema cultures using the SMART-PCR
cDNA Synthesis Kit (Clontech). The primers PpMSH2#4
and PpMSH2#2 (CACCAACACGCGCAAAGATG) were
used for PCR on these cDNAs.
Generation of clean deletion by transient Cre
recombinase expression
Direct repeats of LoxP recombination sites from the Cre/lox
system (19) were located on either side of the 35S-nptII resis-
tance cassette in PpMSH2-KO. Transient expression of a con-
stitutive Cre expression cassette (20) in protoplasts allowed
excision of the resistance gene from the PpMSH2 recombinant
locus (D.G. Schaefer, A. Finka and J.P. Zry¨d, manuscript in
preparation). Protoplasts were regenerated at a low density on
non-selective medium for 2 weeks and fragments of single
protoplast-derived colonies were then replicated on selective
(i.e. G418 50 mg/l) and non-selective medium. Loss of antibi-
otic resistance was determined after an additional week of
growth. Replicates growing on non-selective medium were
used for subsequent amplification and molecular analyses.
Clone Ppmsh2D was selected this way and used for further
analyses. We analyzed by PCR the recombinant locus with the
primers PpMSH2#4 and PpMSH2#2.
Cytology
Binocular observations were made with a Nikon SMZ1000,
and microscopic observations with a Leitz (type 090-122.012)
inverted microscope.
Evaluation of spontaneous mutation frequency
Mutations in the APT gene confer resistance to 2-FA (2-
Fluoroadenine, from Dr Laloue, INRA Versailles, France),
a toxic compound for cells. The number of 2-FA resistant
colonies reflects the frequency of spontaneous mutations. Pro-
toplasts of wild-type and Ppmsh2 mutants were regenerated
for 6 days regeneration on PPM (105/Petri dish) and then
transferred on standard solid medium supplemented with 10
mM 2-FA. After 2 weeks, the number of resistant colonies was
counted. We repeated this experiment three times. The APT
genomic sequence from 2-FA resistant clones was subse-
quently PCR amplified and sequenced to identify the mutation
responsible for the resistance (oligonucleotide sequences can
be provided on request).
Sensitivity to cisplatin/MNU and g/UV-B radiations
Cisplatin (cis-diamminedichloroplatinum(II)) (Calbiochem,
Darnstadt, Germany), MNU (N-methyl-N-nitrosourea) and
O6-bzGua (O6-benzylguanine) (Sigma-Aldrich, Steinheim,
Germany) were dissolved in dimethyl sulfoxide at 100 mM
each for storage at 20C and at 25 mM for O6-bzGua imme-
diately before use.
Wild-type and Ppmsh2 mutant protoplasts in liquid
PPM were treated for 20 h with 0–5 mM cisplatin or MNU
(2 · 105 protoplasts at each concentration). From 1 h before
exposure to MNU and throughout the whole procedure, 25 mM
O6-bzGua was present in the medium to inhibit the removal
of methyl groups from the O6 position of guanine by endoge-
nous methyl-transferase activity. After 20 h in the dark, pro-
toplasts were washed and spread on solid medium at low
concentrations.
Protoplasts in liquid mannitol medium were exposed to
ionizing radiation (1 Gy/s) using a 137Cs irradiator (IBL-
637 CIS-Bio-International, Institut Curie, Orsay). After 20 h
in the dark, the protoplasts were spread on solid medium at low
concentrations.
Protoplasts spread on solid medium (5 · 104 protoplasts at
each concentration in four Petri dishes) were exposed to UV-B
light (60 J/m2/s) from a 312 nm TFX lamp. We calculated the
flux with a UV-Elektronik GmbH dosimeter. The protoplasts
were then left in the dark for 20 h.
After 6 days regeneration, protoplasts were transferred onto
standard solid medium. After 1 week, the number of survivors
was counted. We repeated these experiments two to three
times. Statistical analyses have been made with the c2 test.
APT targeting frequency with homologous and
homeologous DNA
Targeting APT fragments were produced by digestion of
PpAPT-KO vector with NotI and EcoRI enzymes. We selected
stable transformants after transformation of wild-type and
Ppmsh2 mutant protoplasts with homologous and homeolo-
gous APT disruption fragments. Small pieces of protonema
tissue (2 mm in diameter) from stable transformants were
then transferred onto standard medium containing 10 mM of
2-Fluoroadenine to detect APT gene targeting events. Experi-
ments were repeated three times.
RESULTS
Targeted disruption of the MSH2 gene in P.patens
Moss protoplasts were transformed with vector PpMSH2-
KO and four independent clones were selected for further
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investigation (Ppmsh2#1 to Ppmsh2#4). In each clone, disrup-
tion of the chromosomal PpMSH2 locus was controlled by
PCR and absence of the PpMSH2 transcript was established
by RT–PCR (see Ppmsh2#1 for example Figure 1B–D). In
order to obtain a simple deletion mutant, the resistance cassette
inserted at the PpMSH2 locus of the Ppmsh2#1 clone was
eliminated by the CRE recombinase to produce clone
Ppmsh2D (see Materials and Methods and Figure 1A). In
this clone, we confirmed deletion of exon 7 of the PpMSH2
gene by PCR and checked modification of the transcript by
RT–PCR (Figure 1C and D). The four independent PpMSH2
knockouts (Ppmsh2#1 to Ppmsh2#4) and the deletion mutant
(Ppmsh2D) behaved identically under all circumstances tested
except in aged cultures. Therefore, Ppmsh2D mutant was used
for further characterization except for late developmental
phenotypes (see below). To avoid the genetic drift resulting
to the expected mutator phenotype associated with msh2
mutations, all the experiments were performed using the
primary stock of protonema suspension from Ppmsh2D stored
at 4C as starting material.
Ppmsh2 mutants display pleiotropic
developmental defects
The haploid gametophytic development of P.patens from
regenerating protoplasts starts with a filamentous branched
structure called the protonema that grows by apical cell divi-
sions and lateral division of subapical cells. There are two cell
Figure 1. Molecular analysis of Ppmsh2 mutants. (A) Schematic representation of PpMSH2 genomic locus, schematic representation of PpMSH2 disrupted locus
with a double crossover insertion and schematic representation of PpMSH2 disrupted locus without resistance gene. Black open boxes represent exons, black lines
represent introns, gray open boxes are homology regions used to disrupt the gene, black boxes are Lox sites for Cre recombination and arrows show the primers used
for PCR. Ppmsh2Ø is mutant without the resistance gene, resulting from Ppmsh2#1 after Cre recombinase expression. (B) PCR of the recombinant borders with a
primer external to the targeting sequences and one on the resistance gene [primers: PpMSH2#4/Uc for left border (LB) and Lc/PpMSH2#5 for right border (RB)]. (C)
PCR with primers flanking recombination sites (primers: PpMSH2#4/2), (D) RT–PCR for PpMSH2 transcripts (primers: PpMSH2#4/2), PpAPT was used as control.
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types in protonema filaments: chloronema and caulonema.
Regenerating protoplasts first develop into photosynthetically
active chloronemal filaments, formed by cells filled with
chloroplasts and separated by walls perpendicular to the
axis of the filaments. After 5 days, chloronemal apical
cells occasionally differentiate into caulonemal cells charac-
terized by oblique cell walls and smaller and fewer chloro-
plasts. After 8–10 days, primitive meristems called buds
differentiate from caulonemal side branch initials and further
differentiate into leafy shoots, also known as gametophores.
Each leafy shoot resembles a small plant with an unbranched
stem, filamentous basal and aerial rhizoids and leaves display-
ing clear phyllotaxis along the stem axis (21). We found that
the msh2 mutants had several pronounced phenotypes affect-
ing the development of both protonema and leafy shoots.
Gametophytic developmental failures. Preliminary observa-
tions of msh2 mutant colonies regenerated from protoplasts
indicated that these colonies were larger than those obtained
from wild-type protoplasts (data not shown). To further quant-
ify this observation, we compared the size of protonema
filaments by measuring the length of the three apical cells
from 14-day-old regenerated colonies. We found a significant
difference in the mean length between the wild-type and the
Ppmsh2Dmutant (4.2 ± 1 versus 7.2 ± 2, arbitrary units, t-test
P < 0.0001, n ¼ 40) (Figure 2A). These data suggest that the
Ppmsh2D mutant cells elongate 1.5 times faster than the wild-
type cells. We next evaluated the cell division rate in the two
backgrounds by counting the number of cell divisions after
8 days from regenerated protoplasts. We found a significant
difference for mean cell division numbers between the
Figure 2. Comparison of wild type and Ppmsh2 mutants apparent phenotypes: (A) Comparison of the length of the last three cells of protonema filaments; arrows
show the cell walls. (B) Number of cell divisions after 8 days protoplast regeneration; arrows show the cell walls. (C) Wild-type and Ppmsh2Dmutant colonies after
3 weeks development. (D) Male antheridia of wild-type and of Ppmsh2D mutant, (E) female archegonia of wild-type and of Ppmsh2D mutant. (F) Wild-type,
Ppmsh2#1, Ppmsh2#3 and Ppmsh2#2 mutant colonies after 12 weeks development, a representative leafy shoot from those colonies and enlargement of the top of the
same gametophore.
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wild-type and for the Ppmsh2D mutant (5 ± 0.5 versus
6 ± 0.8, t-test P < 0.0001) (Figure 2B), showing that the num-
ber of cell divisions was slightly increased in the mutant.
Differentiation of chloronema cells into caulonema cells
looks normal in the mutant compared with wild type. After
10 days of growth, differentiation of buds and further devel-
opment of leafy shoots could clearly be observed in WT col-
onies whereas, at the same time-point, the Ppmsh2D mutant
colonies had neither developed buds nor leafy shoots and
the protonema was more widespread (data not shown).
After 3 weeks, wild-type colonies had numerous well-
developed leafy shoots, whereas Ppmsh2D filaments had
just developed a few leafy shoots that were thinner, shorter
and occasionally distorted (Figure 2C). We therefore con-
cluded that loss of function of MSH2 seriously impairs the
normal development of P.patens at different levels: protonema
cell growth is accelerated, protonema cell cycle may be
shorter, differentiation of buds is delayed and further devel-
opment of leafy shoots is architecturally affected.
Reproductive developmental failures. The late developmental
stages of P.patens life cycle are the differentiation of repro-
ductive organs, fertilization to produce the diploid sporophyte
and meiosis of spore mother cells to produce haploid spores.
Therefore, we examined whether the developmental abnor-
malities seen at the protonema and leafy shoot stages could
also be observed in antheridia (male) and archegonia (female),
the reproductive organs of P.patens that differentiate at the
apex of leafy shoots. After 10 weeks, the reproductive organs
of wild type were fully developed on leafy shoot (Figure 2D
and E) and the sporophyte further developed normally to
produce viable spores (data not shown). In all five Ppmsh2
mutants, abnormal reproductive organs were formed on the
few leafy shoots (Figure 2C), with aberrant number and shape
of cells (Figure 2D and E). Consequently we never obtained
differentiated capsules from the mutants and concluded that
loss of function of MSH2 led to complete sterility in P.patens.
To determine whether sterility was due to a problem in male
and/or female gametes, reciprocal out-crosses were performed
between Ppmsh2 mutants and strain NicB5ylo6. We did not
obtain any capsules from these crosses and thus concluded that
Ppmsh2 mutants were male and female sterile as a conse-
quence of abortive development of reproductive organs.
Late developmental defects. In order to check the phenotype
of late growing colonies, we inoculated similar size filaments
(5–10 cells) from 3-week-old single protoplasts derived col-
onies on standard medium. After 6 weeks, the mutant colonies
started to become chlorotic and a significant fraction of the
cells were dead (data not shown). After 12 weeks, wild-type
colonies were healthy (Figure 2F, WT) whereas those from
independent Ppmsh2 knockouts presented various develop-
mental aberrations from leaf shape abnormalities (Figure 2F,
Ppmsh2#1) or supernumerary leaves and ‘callus’-like struc-
ture (Figure 2F, Ppmsh2#3) to completely disorganized necro-
tic shoots with numerous aerial rhizoids (Figure 2F,
Ppmsh2#2). Additionally, the frequency of dead cells in these
colonies was directly proportional to the intensity of the
phenotype. In the most dramatic case (Ppmsh2#2) the leafy
shoots were completely dead since isolated gametophores
plated on fresh standard medium were not able to regenerate
viable protonema, which was feasible with WT leafy shoots
isolated from the same culture (data not shown). We also
observed that the intensity of the phenotypes increased pro-
portionally to the number of subcultures the original clone has
undergone (data not shown), suggesting that random mutations
accumulated within Ppmsh2 mutant clones in successive sub-
cultures. Those late phenotypes could clearly be associated
with major developmental processes, such as the establish-
ment of shoot architecture, early senescence and eventually
active cell death. The diversity of the phenotypes observed in
Ppmsh2 mutants supports a strong mutator phenotype that is
immediately detected in the moss haploid gametophyte. For
this reason all the following experiments have been carried out
using 3–4 individual replicates of the primary isolated knock-
out clones (stored at 4C) as starting material.
Ppmsh2 mutants have a mutator phenotype
The strong developmental defects observed in Ppmsh2
mutants could be related to accumulation of spontaneous
mutations. This phenotype has already been observed in
msh2 mutants of other organisms (2). To further quantify
this mutator phenotype, we investigated the effect of the
loss of the PpMSH2 gene on mutation frequency of the adenine
phosphoribosyl transferase (PpAPT) reporter gene. Sponta-
neous mutations leading to loss of APT activity confers resis-
tance to adenine analogues, such as 2-fluoroadenine (2-FA)
and can be selected on standard medium supplemented with
10 mM 2-FA. We tested a total of 107 Ppmsh2D protoplast-
derived colonies and 3 · 106 wild-type colonies for resistance
to 2-FA.
We observed no resistant colonies in the wild type and a
total of 398 2-FA resistant colonies in the Ppmsh2D mutant.
APT mutation frequencies were thus lower than 3 · 107 in
wild type and 4 · 105 ± 1.2 · 105 in Ppmsh2D. To confirm
that 2-FA was effectively resulting from mutation in the APT
gene, we partially sequenced the APT gene of randomly cho-
sen 2-FA resistant clones. Point mutations in the APT sequence
were effectively detected in more than 75% of the clones
tested (Table 1). Mutations resulting from transitions and
transversions were recovered, but we did not identify muta-
tions resulting from insertion or deletion. These modifications
were matching with highly conserved domain or amino acid of
the APT protein and some of them were identified several
Table 1. Point mutations identified in the APT genomic sequence in Ppmsh2D
2-FA resistant clones
Genomic positiona Amino acidb DNA mutation Consequencec
1447 28 GGC!TGC Intron I splicing
1462 33 GAT!TAT D!T
1559 65 GGT!GAT G!D
1687 Intron II AGG!ATG Intron II splicing
2121 108 GGT!GAT G!D
2195 133 GCC!ACC A!T
2464 150 GCG!GAG A!E
2485 157 TGC!TAC C!Y
aPosition 1 corresponds to the first nucleotide in the genomic PpAPT sequence
DQ117987.
bPosition 1 corresponds to the ATG codon in the PpAPT protein.
cUniversal genetic code for amino acid.
6
times in independent 2-FA resistant clones. These results dem-
onstrate that loss of MSH2 gene leads to the accumulation of
point mutations in the moss genome and that the spontaneous
mutation rate is increased at least by two orders of magnitude
(130 times) in the Ppmsh2D mutant compared with the wild
type. This last value is probably underestimated since the
screen used here has selected only mutations that confer
2-FA resistance. Additionally, the type of mutations identified
suggests that they result from defaults of post DNA replication
proofreading processes.
Msh2 mutants display altered responses to
genotoxic stresses
MMR is known to recognize different types of DNA damages
depending on the lesion and on the organism. MMR is respon-
sible for the hypersensitivity to agents, such as radiation or
some genotoxic chemicals that create DNA lesions (22). Loss
of MMR may prevent cell death normally resulting from expo-
sure to such genotoxic agents, thus conferring tolerance to
these stresses. Therefore, we treated Ppmsh2D mutant proto-
plasts with UV-B and g-radiation and chemicals such as cis-
platin and MNU to determine whether P.patens cells with
defective MMR would be affected or not. Survival was cal-
culated as the ratio of protoplasts surviving after 15 days
regeneration following treatment to the number of protoplasts
undergoing normal regeneration without treatment.
Ppmsh2 mutants are equally sensitive to g-radiations than
wild type. Ionizing radiation can cause many different lesions
in DNA, including strand breaks and base or sugar damage
(23,24). Oxidized base damages induced by ionizing radiation
may therefore be substrate for MMR (22). We compared the
effect of g-radiation on the survival of Ppmsh2D mutant and
wild-type protoplasts. We found that both wild-type cells and
Ppmsh2-deficient cells were similarly affected by g-radiation
(Figure 3A). For both genotypes, the LD50 (Lethal Dose 50%)
was reached at 600 Gray. All g-radiation dose comparisons
were not significantly different.
Ppmsh2 mutants are more sensitive to UV-B radiations than
wild type. A high UV-B flux can introduce a number of dif-
ferent lesions into the genome, mostly cyclobutane pyrimidine
dimers (CPDs) and pyrimidine-6-4-pyrimidinone adducts
(6-4PPs) (25). The elimination of these DNA photoproducts
is essential for cell survival because both RNA- and DNA-
polymerase are unable to read through both of these classes of
dimers. Therefore, we tested the effect of increasing UV-B
doses on the survival of regenerated wild-type and Ppmsh2D
mutant protoplasts. We found that wild-type protoplasts were
Figure 3. Survival fraction after different genotoxic stresses. (A) g-radiation, (B) UV-B, (C) Cisplatin, (D) MNU. Wild-type survival is represented with triangles
and dashed line, and Ppmsh2D mutant survival is represented with squares and solid line. Error bars indicate SD based on at least two independent experiments in
all cases.
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affected by high doses of UV-B, with an LD50 of 36 KJ/m
2. In
the Ppmsh2D background, the lethal dose was only 18 KJ/m2
(Figure 3B). All UV-B dose comparisons were significantly
different. These results show that the Ppmsh2D mutant is more
sensitive to UV-B than the wild type.
Ppmsh2 mutants are more tolerant to cisplatin than wild type.
Cisplatin is a DNA-damaging drug that forms bifunctional
covalent adducts with DNA and is a well-recognized mutagen
that affects the survival of mammalian cells (26). We com-
pared survival of wild-type and Ppmsh2D mutant regenerated
protoplasts after exposure to increasing concentrations of cis-
platin. The LD50 for the wild type was 250 mM cisplatin
(Figure 3C), whereas the Ppmsh2D cells were more resistant
than wild-type cells, with an LD50 of about 500 mM. All
concentration comparisons were significantly different.
These experiments show that the Ppmsh2D moss cells have
a cisplatin tolerant phenotype.
Ppmsh2 mutants are more tolerant to MNU than wild type.
The cytotoxicity of methylating agents such as MNU
(N-methyl-N-nitrosourea) is primarily caused by their ability
to introduce O6-methylguanine (O6-meGua) into the DNA
(27). Persistent O6-meGua in the DNA is normally lethal.
Therefore, we determined survival of wild-type and Ppmsh2D
mutant cells after exposure to increasing concentration of
MNU. Wild-type survival was slightly affected by 1 mM
MNU and dramatically affected by 5 mM MNU treatment.
These values are comparable with those reported for MNU-
induced DNA damage in Barley (28). The survival of
Ppmsh2D mutant cells was slightly better than wild type at
1 mM MNU and significantly higher at 5 mM (Figure 3D). The
LD50 was reached at 500 mM for both genotypes. These results
show that Ppmsh2Dmoss cells have a weak resistance to MNU
at high doses.
Gene targeting is decreased and homeologous
recombination is not repressed in Ppmsh2 mutants
In E.coli (29), Saccharomyces cerevisiae (5), Trypanosoma
brucei (30) and mouse embryogenic stem cells (7), depletion
of MutS or MSH2 leads to an increased frequency of recomb-
ination between homeologous DNA sequences. We examined
the involvement of PpMSH2 in HR by measuring GT effici-
ency with homologous or homeologous DNA sequences at the
APT locus. Wild-type and Ppmsh2D cells were transformed
with APT constructs presenting 0, 1, 2 and 3% divergence to
the PpAPT genomic sequence, respectively (Figure 4).
Hygromycin resistant transgenic clones were initially selected
and tested for 2-FA resistance. GT frequency was calculated as
the ratio of 2-FA resistant clones to the total number of
Hygromycin resistant transformants.
We observed a significant decrease (1.8-fold) in GT fre-
quency for mutant cells compared to wild type (P ¼ 0.001)
when the recombination substrate was fully homologous to its
genomic target (Table 2). In wild type, GT frequency
decreased as the percentage of divergence increased, whereas
GT frequency remained stable for the Ppmsh2D mutant what-
ever the divergence level (Table 2). In wild type GT frequency
significantly decreased 22-fold with 3% mismatches compared
to 0% mismatches (c2 test, P < 0.00001), whereas in Ppmsh2D
mutant, the GT was as efficient with homeologous fragments
as with homologous fragment (P ¼ 0.40). Thus, GT efficiency
with a homeologous fragments containing 3% divergence was
increased 15-fold in Ppmsh2D mutant compared to the wild
type. These data demonstrate that loss of function of MSH2
allows GT in P.patens with up to 3% divergent homeologous
sequences, hence that the moss MSH2 protein has an antire-
combination activity that prevents recombination between
slightly divergent sequences.
DISCUSSION
Ppmsh2 mutants show strong developmental defects, are
sterile and have a mutator phenotype
Ppmsh2 mutant colonies develop strong developmental
defects, including sterility, after a few weeks. This sterility
may be due to the msh2 associated mutator phenotype increas-
ing the rate of mutations that cause developmental problems in
complex structures such as leafy shoots, antheridia and
archegonia. Similar phenotypes have been observed in Ara-
bidopsis thaliana msh2 mutant lines (10). After five genera-
tions, plants showed abnormalities in morphology and
development, fertility, germination efficiency, seed/silique
development and seed set. In human and mice, mutations in
MSH2 result in a greatly increased likelihood of developing
certain types of tumors (31). As in other eukaryotes, during
growth and development, MSH2 in moss seems to be essential
for the maintenance of genome integrity. Accordingly, we
scored a 130-fold increase in the spontaneous mutation rate
Figure 4. Gene targeting PpAPT fragments used for homologous and home-
ologous recombination studies. The hygromycin gene resistance cassette is
represented between both PpAPT fragments by a horizontal interrupted line.
(A) PpAPT fragments in the PpAPT-KO cassette in which the sequences are
exactly identical to the locus PpAPT used as reporter gene. (B) Alignments of
PpAPT fragments in homeologous recombination cassettes; each vertical line
indicates mismatch between mutated PpAPT fragments and the original locus.
Table 2. Gene targeting frequency in wild type and Ppmsh2D mutant
Genotypes
Divergence (%) Wild type Ppmsh2D
0 44% (90/204)a 24% (68/278)a
1 14% (11/81)a 31% (14/45)a
2 9% (4/46)a 20% (4/20)a
3 2% (2/124)a 30% (29/96)a
aPercentagescorrespond to GT frequency,which is the number of 2-FA resistant
clones divided by the number of stables hygromycin resistant clones, indicated
in brackets.
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of the APT gene in Ppmsh2 mutants compared with wild type.
This increased mutation rate is comparable with those
observed in E.coli mutS mutant (20-fold increase) (32), or
S.pombe (15-fold increase) (33) and S.cerevisiae (200-fold
increase) (8) and other higher eukaryotes msh2 mutants
(from 30- to several hundred-fold increase (7,10,34,35).
This mutation rate can explain the phenotypes observed in
the Ppmsh2 mutants. Assuming that the amount of mutations
increases with the number of rounds of DNA replication,
abnormalities should increase with the number of generations
of vegetative propagation and this is what we observed after
multiple successive subcultures of the colonies. Nevertheless,
the phenotypes we observed in the mutant background are
particularly strong, and two explanations can be proposed
to account for this observation. The first one is linked to
the fact that the major part of the moss life cycle is haploid.
Thus, the deleterious effects of mutations in development are
greater in moss than for diploid mice or A.thaliana, where the
allelic locus would mask the phenotype resulting from ran-
domly occurring mutations, at least in the first generation.
Moreover, we cannot discard the hypothesis that, as in budding
yeast, efficient GT in P.patens reflects the predominance of the
HR pathway in the repair of DNA DSB. In this case, alteration
of the MMR system, which participates in this DNA repair
pathway, would lead to more drastic effects than in other
higher eucaryotes, where HR is not the major pathway for
DNA DSB repair. This is reminiscent of the strong reduction
in spore viability observed in the msh2 yeast mutant (36) an
organism where HR is also predominant.
Is PpMSH2 protein involved in cell-cycle checkpoints
and apoptosis-induced by genotoxic stresses?
The sensitivity of cells to agents that create lesions on DNA
has been attributed to attempts of MMR to correct the resulting
damage (22). Depending on the type of DNA damage, loss of
MMR may result in increased mutagenesis, loss of cell-cycle
control and resistance to apoptosis (37). The resistance of
msh2-deficient cells to DNA damage is not so clear because
it depends on the organism and on the specificity of the lesions.
In C.elegans, MSH2 confers sensitivity to ionizing radiation
(9). In mouse cells, conflicting results have been reported,
although the effects are generally minor. Msh2-nullizygous
cells were found to exhibit slight higher levels of survival
after exposure to ionizing radiation (38,39). However, it has
recently been shown that both mouse embryogenic fibroblasts
(MEFs) and mouse colorectal carcinoma cells defective in
MSH2 were slightly more sensitive (1.5-fold) to X-ray irra-
diation than their MSH2-non-defective counterparts (40). In
contrast, in moss, as in drosophila and human cells, the loss of
MSH2 does not affect the sensitivity to g-radiation, suggesting
that MSH2 is not involved in the detection of lesions due to
g-radiation (41,42).
In E.coli, T.brucei, mouse and human cells, MSH2 confers
sensitivity to MNU (27,38,43,44). In contrast, in the yeast
S.cerevisiae, the MMR system did not affect sensitivity to
methylating agents (45). In our experiments, Ppmsh2 mutants
showed only a weak resistance to MNU at high concentration.
This suggests that only a fraction of the MNU cytotoxicity in
moss cells may be dependent on MSH2 function. Other
mechanisms must be involved to repair DNA lesion in
conjunction or not with MMR. HR can repair DNA lesions,
like it has been shown in yeast for O6-meGua damages (45).
Absence of MMR in S.cerevisiae did not affect sensitivity to
methylating agents, while HR inactivation sensitized cells to
this agent. In HR-deficient cells, defects in the MSH2 gene
rescue the original sensitivity (45). These authors conclude
that methylation damage processing and repair by HR masks
the sensitivity of MMR-proficient S.cerevisiae cells toward
methylating agents (45). In our experiments, Ppmsh2 mutants
showed a weak resistance to MNU only at high concentration,
suggesting that only a fraction of the MNU cytotoxicity in
moss cells may be dependent on MSH2 function. Like in yeast,
moss MMR could be overwhelmed by other mechanisms such
as HR, thus preventing the cytotoxicity due to methylating
agents to be detectable in wild type.
Peters et al. (37) have shown that in MEF (mouse embryo-
genic fibroblasts), MSH2 may sense damage due to photoprod-
ucts or may contribute to the processing of UV-B-induced
DNA damage, thereby initiating apoptosis and influencing
the activation of p53 (a tumor suppressor which functions
as a transcription factor involved in cell-cycle checkpoints
and apoptosis). They showed that Msh2-null MEFs were par-
tially resistant to the cytotoxic effects of UV-B, and that this
resistance led to a reduction in apoptosis. In contrast, we have
shown that the Ppmsh2 mutant is more sensitive to UV-B
radiation than the wild type. Therefore, MSH2 in moss may
play a more important role in the recognition of UV-B lesions
than that reported in MEF.
Experiments in E.coli have shown that loss of MMR activ-
ity, due to mutations in mutS, was correlated with cisplatin
resistance (46,47). There are conflicting results in the response
of cisplatin treatment in higher eukaryotes. It was thought
that mouse MSH2 conferred sensitivity to cisplatin (48).
However, Claij and te Riele (49) have recently shown that
msh2-deficient mouse cells do not respond specifically to cis-
platin lesions compared with wild type (49). In contrast, data
from Trypanosoma cruzei have demonstrated a role of MSH2
in sensitivity to cisplatin (50), like in prokaryotes and in yeast
(46,51). Our results in moss show that Ppmsh2 mutants are
tolerant to cisplatin.
The fact that Ppmsh2 mutants have opposite responses to
lesions due to UV-B (sensitivity) and cisplatin (resistance)
suggests that moss may have different pathways for managing
lesions involving PpMSH2 proteins. PpMSH2 may signal
DNA lesions and induce cell-cycle arrest followed by either
DNA repair or apoptosis to prevent accumulation of a large
number of mutations. In the absence of PpMSH2, we suggest
that, depending on the type of DNA lesions, different res-
ponses may be engaged. When the lesion is too severe (expo-
sure to UV-B), the cells are unable to repair them and die. For
other lesions, they can be bypassed by a translesion synthesis
polymerase (52,53) or be repaired by other mechanisms such
as base excision repair, nucleotide excision repair or by HR
(45,54,55). In these cases, the cells can survive almost norm-
ally, as observed with moss msh2 mutant cells exposed to
cisplatin. We suggest that in wild-type cells, the DNA lesions
caused by cisplatin trigger cell death and/or prolonged cell-
cycle arrest through PpMSH2. We have evidence that the cell
cycle is perturbed in the absence of PpMSH2: during the
regeneration of protoplasts, Ppmsh2 mutants showed a slightly
higher rate of cell division compared with the wild type. This
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suggests that Ppmsh2 mutants may have an accelerated cell
cycle, which may be explained if there was shorter arrest at
cell-cycle checkpoints. Indeed, in mice it has been shown that
after DNA damage, the absence of MSH2 results in premature
release from the early G2/M arrest and an inability to activate
properly the checkpoint kinase proteins (40). It was suggested
that an active MSH2 is required for a correct response to
DNA damage in the G2 phase of the cell cycle, possibly
connecting DSB repair to checkpoint signaling. Moreover,
in human, MMR is required for S-phase and G2-M checkpoint
regulation (56,57). Consistent with these findings, we suggest
that PpMSH2 is required for efficient cell-cycle arrest induced
by DNA damage and may be a key component acting on
DNA damage-activated checkpoints.
PpMSH2 is involved in HR and is essential to
homeologous recombination
We examined the influence of MMR on HR in P.patens by
assaying the frequency of recombination between a foreign
DNA fragment released in vivo and a genomic target sequence.
We found that the frequency of GT via HR between identical
DNA was decreased 1.8-fold in the Ppmsh2-defective cells
compared with the wild type. In mice, msh2 mutants show a
slight decrease of GT efficiency with homologous fragment
compared with wild-type mice, and this decrease is compara-
ble with our results (1.5-fold) (7). In yeast, a recent study has
shown that the frequency of GT was reduced 3- to 4-fold in the
msh2 strain (58). Together with our results, these suggest that
MSH2 in P.patens is probably involved in mechanisms that
regulate GT of perfectly matching sequences in the genome.
Further analyses are needed to determine the mechanisms
involved.
We tested the influence of MMR on homeologous recomb-
ination in P.patens by assaying the frequency of recombina-
tion between a mutated DNA fragment and a genomic target
sequence. Our results show that DNA sequence identity is
important to determine the efficiency of gene replacement
in the wild type. We have also shown that lack of PpMSH2
allows homeologous sequences with up to 3% divergence to be
as efficiently targeted as perfectly identical sequences to a
genomic locus. This shows that PpMSH2 plays a major role
to prevent recombination between homeologous sequences.
This is consistent with the similar role described for MMR
in E.coli (29), in Trypanosoma (30), in yeast (5) and in mouse
cells (7,59,60), suggesting that this role of MSH2 is strongly
preserved during evolution. However, this is the first time that
MSH2 involvement in HR and homeologous recombination is
shown in plants.
In conclusion, we have found that in moss, MSH2 is
involved in mismatch recognition and repair that most likely
results from DNA replication errors, and in the response to
certain genotoxic agents. Moreover, MSH2 plays a role in HR
and in the recognition of mismatches that occur during het-
eroduplex formation between two not perfectly complemen-
tary DNA strands. These mechanisms are essential for
maintaining genome integrity in all organisms and to establish
interspecific barrier. This is particularly true for plants as they
are unable to move and must cope with exposure to environ-
mental mutagens. Thus, an efficient mechanism for genomic
stability is needed in plants, and even more in mosses, where
the major developmental stage of the life cycle is the haploid
gametophyte. This is emphasized by the dramatic deleterious
effect on development observed in an msh2 P.patens mutant
compared with its A.thaliana counterpart. Our results show for
the first time, the crucial role of MMR in a pluricellular organ-
ism where HR seems to be one of the major pathways to repair
DNA lesions.
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